Profile
ACER VRTX VRNA REGN ALNY ARGX
Company Name Acer Therapeutics Inc. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap - $108.04B $72.68B $68.01B $60.75B $50.28B
Employees 0.03K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO Christopher Schelling Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
ACER VRTX VRNA REGN ALNY ARGX
Quant Rating Score 3 3 1 4 1 3
Quant Rating Neutral Neutral Strong Sell Buy Strong Sell Neutral
Trading
ACER VRTX VRNA REGN ALNY ARGX
Last Close $0.6601 $417.21 $106.91 $652.91 $481.59 $821.97
High 52 $0.9 $516.74 $106.91 $922.79 $491.09 $849.46
Low 52 $0.66 $366.54 $33.93 $482.92 $224.58 $532.27
Price vs. 52 Week High -26.66 % -19.26 % 0 % -29.25 % -1.93 % -3.24 %
Price vs. 52 Week Low 0.02 % 13.82 % 215.09 % 35.2 % 114.44 % 54.43 %
Total Return
ACER VRTX VRNA REGN ALNY ARGX
1 Month Return 0 % 6.53 % 0.17 % 16.12 % 5.63 % 11.42 %
3 Month Return 0 % -11.07 % 1.68 % 17.71 % 41.85 % 37.25 %
6 Month Return 0 % -18.11 % 48.2 % 9.05 % 82.89 % 27.56 %
9 Month Return 0 % -4.83 % 86.77 % -4.42 % 73.76 % 23.48 %
YTD Return 0 % 3.6 % 130.21 % -8.34 % 104.66 % 33.65 %
1 Year Return -26.66 % -12.18 % 212.69 % -29.25 % 71.09 % 48.99 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACER VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.4 % - -
Dividend Paid and Capex Coverage Ration (TTM) -176.74 % 11.09 % -147.93 % 4.25 % -0.43 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Growth
ACER VRTX VRNA REGN ALNY ARGX
Asset Growth -67.94 % -0.87 %
Gross Profit Growth -100 % 10.25 %
Revenue Growth -100 % 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year 100 % 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -63.88 % -93.69 %
Net Income Growth -70.66 % -114.8 %
Net Income 3 Yeari Growth Per Share 42.91 % -122.89 %
Net Income 5 Yeari Growth Per Share 56.69 % -145.38 %
Net Income 10 Yeari Growth Per Share 98.53 % 33.84 %
Operating Income Growth -54.34 % -106.08 %
Operating Cash Flow Growth (CFG) -22323.93 % -113.93 %
Operating 3 Year CFG 34.38 % -118.65 %
Operating 5 Year CFG 49.72 % -131.3 %
Operating 10 Year CFG 98.3 % 12.43 %
EPS Growth -71.84 % -114.8 %
EPS Diluted Growth -71.84 % -114.97 %
Book Value Per Share -780 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -158.4 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -117.58 % 168.85 %
Share Holder 10 Year Equity Growth Per Share -102.91 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth 2912.5 % 116.42 %
Free Cash Flow Growth -15924.54 % -124.1 %
Updated On 31 Dec 2022 31 Dec 2024
Profitability
ACER VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM - 86.11 % 95.15 % 85.39 % 83.64 % 65.82 %
Return on Assets TTM -225.71 % 15.13 % -14.17 % 11.4 % -6.99 % 15.06 %
Return on Equity TTM 283.88 % 22.14 % -38.66 % 15.31 % -274.21 % 18.96 %
Return on Capital Employed TTM 335.91 % 19.72 % -10.74 % 10.32 % -5.52 % 5.04 %
Net Income Per EBT TTM 100 % 83.16 % 111.3 % 88.98 % 84.06 % 237.3 %
EBT Per Ebit TTM 106.59 % 111.48 % 130.22 % 139.5 % 210.66 % 147.38 %
EBIT Per Revenue TTM - 34.36 % -25.27 % 25.89 % -7.32 % 13.47 %
Cash Flow To Debt Ratio TTM -254.98 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Receivables Turnover TTM - 6.03 2.55 2.51 4.34 1.91
Payables Turnover TTM - 3.59 3.13 2.3 3.93 0.9
Inventory Turnover TTM - 1.06 1.25 0.64 5.62 2.26
Fixed Asset Turnover TTM - 431.08 % 8642.22 % 284.82 % 355.68 % 5009.77 %
Asset Turnover TTM - 47.51 % 38.7 % 35.47 % 53.92 % 31.97 %
Operating Cash Flow Per Share TTM -1.92 14.98 -0.85 48.94 -0.12 5.67
Free Cash Flow Per Share TTM -1.93 13.63 -0.85 40.09 -0.4 5.58
Cash Per Share TTM 14.77 % 2486.48 % 511.44 % 8148.65 % 2203.63 % 5536.58 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -32.7 % 35.59 % -0.63 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.57 % 90.99 % 100.75 % 81.92 % 335.21 % 98.47 %
Cash Flow Coverage Ratios TTM -254.98 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Price To Free Cash Flows Ratio TTM - 30.87 -995.27 16.37 -1166.22 132.81
Price To Operating Cash Flows Ratio TTM -0.34 28.12 -126.33 13.34 -3867.41 151.69
Price Cash Flow Ratio TTM -0.34 28.12 -126.33 13.34 -3867.41 151.69
Income Statement (TTM)
ACER VRTX VRNA REGN ALNY ARGX
Revenue $0B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $0B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0.02B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.03B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -1.77 -2.08 -1.73 38.34 -2.16 12.78
Balance Sheet (MRQ)
ACER VRTX VRNA REGN ALNY ARGX
Long Term Debt $0.01B $1.66B $0.12B $2.7B $1.25B $0.03B
Total Liabilities $0.03B $6.12B $0.27B $8.41B $4.17B $0.7B
Total Equity $-0.02B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0B $6.65B $0.02B $15.42B $1.73B $1.93B
Total Debt $0.01B $1.75B $0.12B $2.7B $1.3B $0.04B
Total Assets $0.01B $22.53B $0.47B $37.76B $4.24B $6.2B
Cash Flow Statement (TTM)
ACER VRTX VRNA REGN ALNY ARGX
Net Income $-0.03B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 32.9
AARD Aardvark Therapeutics, Inc. Common Stock 11.38
ABCL AbCellera Biologics Inc. 5.57
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.07
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.26
ABPWW 0.0142
ABSI Absci Corporation 4.29
ABUS Arbutus Biopharma Corporation 4.69
ABVC ABVC BioPharma, Inc. 2.855
ABVX Abivax SA American Depositary Shares 103.151
ACAD ACADIA Pharmaceuticals Inc. 22.6088
ACET Adicet Bio, Inc. 0.7838
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.91
ACIU AC Immune SA 3.785
ACLX Arcellx, Inc. 85.78
ETFs With Exposure to ACER
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 336.77
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.55
IWC iShares Micro-Cap ETF 0.0034 154.88
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.03 41.2482
Unlock